Radiant Heat Systemic Hyperthermia Clinical Trials

  • H. Ian Robins
  • Justin D. Cohen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 267)


Results of a Phase I study led our group to the conclusion that a radiant heat system provides a safe and effective method of inducing 41.8°C whole body hyperthermia (WBH) which is suitable for combination therapy. The review to follow summarizes our progress in combining WBH with other cancer-treatment modalities, including ionizing irradiation, chemotherapy and immunotherapy.


Total Body Irradiation Allogeneic Bone Marrow Transplantation Isolate Limb Perfusion Metabolic Heat Production Central Nervous System Toxicity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barlogie, B., Corry, P.M. and Drewinko, B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum (II) and mitomycin C. Cancer Res. 40: 1165–1168, 1980.PubMedGoogle Scholar
  2. 2.
    Calvert, A.H., Harland, S.J., Newell, D.R., Siddik, Z.H., Jones, A.C., McElwain, R.S., Wiltshaw, E., Smith, I.E., Baker, J.M., Peckham, M.J., and Harrap, K.R. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother. Pharmacol. 9: 140147, 1982.Google Scholar
  3. 3.
    Cohen, J.D., and Robins, H.I. Hyperthermic enhancement of cisdiammine-1,1-cyclobutane dicarboxylate platinum (II) cytotoxicity in human leukemia cells in vitro. Cancer Res. 47: 4335–4337, 1987.PubMedGoogle Scholar
  4. 4.
    Cohen, J.D., Robins, H.I., and Schmitt, C.L. Interactions of hyperthermia with carboplatin, cisplatin, and etoposide in human leukemia cells in vitro Cancer Letters, in press, 1989.Google Scholar
  5. 5.
    Dennis, W.H., and Robins, H.I. The need for analysis of modern technologies for health care prior to development. (In) Applied Systems and Cybernetics, vol. 4, pp. 1744–1749, New York, Pergamon Press, 1981.Google Scholar
  6. 6.
    Gerad, H., Egorin, M.J., Whitacre, M., Van Echo, D.A., and Aisner, J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diammine-dichloroplatinum (II) and whole body hyperthermia. Cancer Chemother. Pharmacol. 11: 162–166, 1983.Google Scholar
  7. 7.
    Koeller, J.M., Trump, D.L., Tutsch, K.D., Earhart, R.H., Davis, T.E., and Tormey, D.C. Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion. Cancer 57: 222–225, 1986.PubMedCrossRefGoogle Scholar
  8. 8.
    Meyn, R.E., Corry, P.M., Fletcher, S.E., and Demetriades, M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum (II). Cancer Res. 40: 1136–1139, 1980.PubMedGoogle Scholar
  9. 9.
    Mong, S., Huang, C.H., Prestayko, A.W., and Crooke, S.T. Effects of second-generation platinum analogs on isolated PM-2 DNA and their cytotoxicity in vitro and in vivo. Cancer Res. 40: 3318–3322, 1980.PubMedGoogle Scholar
  10. 10.
    Riviere, J.E., Page, R.L., Dewhirst, M.W., Tyczkowska, K., and Thrall, D.E. Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs. Int. J. Hyperthermia 2: 351–358, 1986.CrossRefGoogle Scholar
  11. 11.
    Robins, H.I. The role of whole body hyperthermia in the treatment of neoplastic disease, its current status and future prospects. Cancer Res. 44: 4878s - 4883, 1984.PubMedGoogle Scholar
  12. 12.
    Robins, H.I., Cohen, J.D., and Schmitt, C.L. The relationship of thermal enhancement (TE) to temperature for carboplatin (CBDCA). Rad. Res., NAGH, Seattle, WA, March 18–23, 1989.Google Scholar
  13. 13.
    Robins, H.I., Dennis, W.H., Martin, P.A., Sondel, P.M., Yatvin, M.B., and Steeves, R.A. Potentiation of differential hyperthermic sensitivity of AKR leukemia and normal bone marrow cells by lidocaine or thiopental. Cancer 54: 2831–2835, 1984.PubMedCrossRefGoogle Scholar
  14. 14.
    Robins, H.I., Dennis, W.H., Neville, A.J., Hugander, A., Shecterle, L.M., Martin, P.A., Gillis, W.K., Grossman, J., Steeves, R.A., and Davis, T.E. Whole body hyperthermia clinical trials. Proc. IEEE/Engineering Medicine and Biology Society 1: 361–364, 1985.Google Scholar
  15. 15.
    Robins, H.I., Dennis, W.H., Neville, A.J., Shecterle, L.M., Martin, P.A., Grossman, J., Davis, T.E., Neville, S.R., Gillis, W.K., and Rusy, B.F. A nontoxic system for 41.8°C whole body hyperthermia: Results of a Phase I study using a radiant heat device. Cancer Res. 45: 3937–3944, 1985.PubMedGoogle Scholar
  16. 16.
    Robins, H.I., Dennis, W.H., Slattery, J.S., Lange, T.A., and Yatvin, M.B. Systemic lidocaine enhancement of hyperthermia-induced tumor regression in transplantable murine models. Cancer Res. 43: 31873191, 1983.Google Scholar
  17. 17.
    Robins, H.I., Dennis, W.H., Steeves, R.A., and Sondel, P.M. A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia. J. Clin. Oncol. 2: 1050–1056, 1984.PubMedGoogle Scholar
  18. 18.
    Robins, H.I., Grossman, J., Davis, T.E., Dennis, W.H., and AuBuchon, J.P. A preclinical trial of a radiant heat device for whole body hyperthermia using a porcine model. Cancer Res. 43: 2018–2022, 1983.PubMedGoogle Scholar
  19. 19.
    Robins, H.I., Hugander, A., Besozzi, M., Schmitt, C.L., Martin, P.A., Zager, L.V., and Grossman, J. Beta-blockade during whole body hyperthermia: A toxicity study in the dog. J. Comp. Vet. Oncology, in press.Google Scholar
  20. 20.
    Robins, H.I., Hugander, A., Steeves, R., and Dennis, W.H. Radiotherapy and hyperthermia for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 12: 147, 1986.PubMedGoogle Scholar
  21. 21.
    Robins, H.I., Kalin, N., Shelton, S.E., Martin, P.A., Shecterle, L.M., Barksdale, C.N., Neville, A.J., and Marshall, J. Rise in plasma beta-endorphin, ACTH, and cortisol in cancer patients undergoing whole body hyperthermia. Horm. Metab. Res. 19: 441–443, 1987.PubMedCrossRefGoogle Scholar
  22. 22.
    Robins, H.I., Kalin, N., Shelton, S.E., Shecterle, L., Marshal, J., and Barksdale, C.N. Neuroendocrine changes in patients undergoing whole body hyperthermia. Int. J. Hyperthermia 3: 99–105, 1987.CrossRefGoogle Scholar
  23. 23.
    Robins, H.I., Longo, W.L., Hugander, A., Bozdeck, M., Schwartz, B., Steeves, R.A., Flynn, B., Trigg, M., and Sondel, P.M. Whole body hyperthermia combined with total body irradiation and chemotherapy as a preparative regimen for allogeneic bone marrow transplantation. Cancer J. 1: 180–183, 1986.Google Scholar
  24. 24.
    Robins, H.I., Longo, W.L., Lagoni, R.K., Neville, A.J., Riggs, C., Schmitt, C.L., Hugander, A., and Young, C. A Phase I trial of lonidamine with whole body hyperthermia in advanced cancer. Cancer Res. 48: 6587–6592, 1988.PubMedGoogle Scholar
  25. 25.
    Robins, H.I., Longo, W.L., Schmitt, C.L., Lagoni, R.K., Neville, A.J., Giese, W., and Steeves, R.A. Whole body hyperthermia and total body irradiation in the treatment of B cell neoplasm. Proc. 5th Int. Symp. Hyperthermie Oncol., in press, 1988.Google Scholar
  26. 26.
    Robins, H.I., Longo, W.L., Steeves, R.A., Lagoni, R.K., Hugander, A., Neville, A.J., O’Keefe, S., Giese, W., and Schmitt, C.L. A pilot study of whole body hyperthermia and local irradiation for advanced nonsmall cell lung cancer confined to the thorax. Inter. J. Radiat. Oncol. Biol. Phys. 15: 427–431, 1988.CrossRefGoogle Scholar
  27. 27.
    Robins, H.I., and Neville, A.J. Biology and methodology of whole body hyperthermia. In: Hyperthermia in Cancer Treatment, vol. 3, L.V. Anghileri and J. Robert, eds., CRC Press, Boca Raton, FL, 1986, pp. 184–206.Google Scholar
  28. 28.
    Robins, H.I., Sielaff, K.M., Storer, B., Hawkins, M.J., and Borden, E.C. A Phase I trial of interferon-aLy with whole body hyperthermia in advanced cancer. Cancer Res. 49: 1989.Google Scholar
  29. 29.
    Roseman, J.M., Tench, D., and Bryant, L.R. The safe use of cisplatin in hyperthermie isolated limb perfusion systems. Cancer 56: 742–744, 1985.PubMedCrossRefGoogle Scholar
  30. 30.
    Rozenzweig, M., von Hoff, D.D., Slavik, M., and Muggia, F.M. Cis-diammine-dichloro (II), a new anticancer drug. Ann. Int. Med. 86803–812, 1977.Google Scholar
  31. 31.
    Steeves, R., Robins, H.I., Miller, K., Shecterle, L., Kruk, M., and Dennis, W. Interaction of whole body hyperthermia and irradiation in the treatment of AKR mouse leukemia. Int. J. Radiat. Biol. 52: 935–947, 1987.CrossRefGoogle Scholar
  32. 32.
    Tapazoglou, E., Robins, H.I., Khatana, A., Schmitt, C.L., Cohen, J., Franken, K., Corry, P., and Sapareto, S.A. The enhancement of cytotoxicity of carboplatin (CBDCA) by whole body hyperthermia (WBH) in the murine AKR leukemia. AACR Abstract 29: 1342, 1988.Google Scholar
  33. 33.
    Tapazoglou, E., Robins, H.I., Khatana, A., Schmitt, C.L., Cohen, J., Franken, K., Corry, P., and Sapareto, S.A. Whole body hyperthermia (WBH) potentiation of carboplatin (CBDCA) cytotoxicity in murine AKR leukemia. Rad. Res. Soc.-NAHG Abstract Cd-13, 1988.Google Scholar
  34. 34.
    Wondergem, J., Bulger, R.E., Strebel, F.R., Newman, R.A., Travis, E.L., Stephens, L.C., and Bull, J.M.C. Effect of cis-diamminedichloroplatinum (II) combined with whole body hyperthermia on renal injury. Cancer Res. 48: 440–446, 1988.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • H. Ian Robins
    • 1
  • Justin D. Cohen
    • 2
  1. 1.Departments of Human Oncology, Medicine Neurology and Veterinarian MedicineUniversity of WisconsinMadisonUSA
  2. 2.Department of Human OncologyUniversity of WisconsinMadisonUSA

Personalised recommendations